![]() |
市場調查報告書
商品編碼
1953452
外科牽開器市場 - 全球產業規模、佔有率、趨勢、機會及預測(按類型、產品、應用、地區和競爭格局分類,2021-2031年)Surgical Retractors Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Product, By Application, By Region & Competition, 2021-2031F |
||||||
全球外科牽開器市場預計將從 2025 年的 15.2 億美元成長到 2031 年的 19.9 億美元,複合年成長率為 4.59%。
這些專用醫療器械對於分離切口邊緣、保護皮下組織和器官至關重要,能夠為外科醫師提供最佳的手術視野和操作空間。推動市場成長的關鍵因素包括全球人口老化以及需要手術介入的慢性疾病盛行率不斷上升。此外,全球手術數量的持續成長也促進了對這些關鍵器械的持續需求。
| 市場概覽 | |
|---|---|
| 預測期 | 2027-2031 |
| 市場規模:2025年 | 15.2億美元 |
| 市場規模:2031年 | 19.9億美元 |
| 複合年成長率:2026-2031年 | 4.59% |
| 成長最快的細分市場 | 手持式 |
| 最大的市場 | 北美洲 |
然而,由於嚴格的消毒監管以及可重複使用醫療設備相關的手術部位感染風險,市場面臨巨大的挑戰。醫療機構必須不斷權衡這些嚴格的安全通訊協定與成本限制和營運效率之間的關係。醫療資源的緊張狀況體現在對外科專家的巨大需求上。根據美國醫學院協會預測,到2024年,美國將需要約16萬名外科醫生才能滿足其人口的醫療保健需求。
微創手術中專用牽開器的日益普及是推動該市場發展的關鍵因素,從根本上改變了全球醫院的器械需求。現代外科手術通訊協定優先考慮能夠最大限度減少患者身體不適的技術,這就要求牽開器具備高精度、低輪廓的特點,能夠在有限的手術視野內有效發揮作用。機器人輔助手術的普及就清晰地體現了這一轉變,這類手術利用客製化設計的牽開系統(通常是手動或自動的)來增強手術視野,而無需進行大切口。根據Intuitive Surgical公司於2024年2月發布的2023年10-K報告,全球達文西手術量年增約22%。這種高難度手術的成長與對相容的、通常符合人體工學或具有照明功能的器械的需求直接相關,以確保在複雜的內部操作過程中的安全。
同時,對重組和美容手術的需求不斷成長,推動了專用於美容用途的牽引裝置的採購。這些裝置必須確保最佳的手術視野,同時最大限度地減少組織損傷,以維持美容效果,並且需要各種形狀和尺寸,以適應體型雕塑、乳房和臉部手術等不同需求。正如國際美容整形外科學會於2024年6月發布的《2023年全球調查結果》中所述,預計全球整形外科醫師將進行約1,580萬例手術,顯示這些裝置的應用領域十分廣闊。如此高頻率的擇期手術迫使醫療機構維持大量的耐用醫療設備庫存。因此,外科器械的總投資仍居高不下。據史賽克公司稱,其醫療外科和神經技術部門2024年的淨銷售額為118億美元,反映出該公司持續對必要的外科耗材和技術進行大量資本投入。
嚴格的消毒法規以及可重複使用器械相關的手術部位感染風險,對全球手術牽開器市場構成了重大障礙。監管機構日益強制要求實施嚴格且耗時的再處理通訊協定,以降低複雜手術器械固有的污染風險。這些要求迫使醫療機構在專業消毒基礎設施和人事費用投入巨資,顯著增加了可重複使用牽開器的營運成本和處理時間。這導致手術流程效率低下,進而造成手術量減少,並使醫療機構不願增加其先進可重複使用器械的庫存。
消毒失敗造成的嚴重經濟損失進一步加劇了營運負擔。當再處理通訊協定不完全時,所引發的感染疾病會耗盡醫院預算,而這些預算原本可以用來購買新設備。根據感染控制與流行病學專業人員協會 (APIC) 統計,到 2024 年,手術部位感染會使平均住院時間延長約 10 天,並導致每位患者額外支出約 2 萬美元。如此巨大的經濟負擔迫使醫療機構優先考慮感染控制合規性和糾正措施,而非購買新的手術器械,直接阻礙了整個市場的成長。
為減少手術部位感染並簡化繁瑣的再處理流程,一次性牽開器的日益普及正在重塑市場格局。這些器材擴大整合了先進功能,例如無線LED照明,無需光纖電纜即可增強對深腔的可視性。領先製造商的財務表現也印證了這一轉變,他們正投資於一次性技術以滿足更高的滅菌標準。根據庫柏公司(Cooper Companies)在2025年5月舉行的「2025年第二季公佈財報」中透露,其旗下OBP Surgical品牌的無線一次性手術牽開器產品組合實現了31%的收入成長,凸顯了這些無菌即用型器械在臨床環境中的快速普及。
同時,隨著急診手術從住院部轉向門診部,門診手術中心(ASC)對小型牽開器系統的需求也在加速成長。這種轉變需要專門設計、節省空間的器械,以便在門診手術中心精簡的基礎設施內進行複雜的整形外科和重組手術。例如,門診關節置換術的擴展需要堅固耐用且符合人體工學的牽開器,以便在較小的手術室中有效運作。根據果凍 Partners 公司 2025 年 11 月的“2025 年第三季度財報電話會議”,該公司門診機構的年度累計全關節置換術同比成長 23%,表明門診手術室對專用牽開器的需求顯著成長。
The Global Surgical Retractors Market is projected to expand from USD 1.52 Billion in 2025 to USD 1.99 Billion by 2031, registering a CAGR of 4.59%. These specialized medical instruments are essential for separating incision edges and restraining underlying tissues or organs, thereby affording surgeons optimal visibility and access to the operative field. The primary factors driving this market growth include the globally aging population and the rising prevalence of chronic diseases that require surgical intervention. Furthermore, the worldwide increase in surgical procedure volumes serves as a foundational catalyst for the sustained demand for these critical tools.
| Market Overview | |
|---|---|
| Forecast Period | 2027-2031 |
| Market Size 2025 | USD 1.52 Billion |
| Market Size 2031 | USD 1.99 Billion |
| CAGR 2026-2031 | 4.59% |
| Fastest Growing Segment | Handheld |
| Largest Market | North America |
However, the market faces a significant challenge due to the stringent regulatory landscape concerning sterilization and the associated risks of surgical site infections linked to reusable devices. Healthcare providers must constantly balance these rigorous safety protocols against cost constraints and operational efficiency. This strain on medical resources is highlighted by the immense demand for surgical professionals; according to the Association of American Medical Colleges, the United States required approximately 160,000 surgeons in 2024 to meet the population's medical needs.
Market Driver
The increasing adoption of specialized retractors for minimally invasive surgery serves as a major market accelerator, fundamentally changing instrumentation requirements for hospitals globally. Modern surgical protocols increasingly prioritize techniques that minimize patient trauma, requiring high-precision, low-profile retractors that function effectively within confined operative fields. This shift is clearly demonstrated by the surge in robotic-assisted procedures, which utilize distinct, often specialized manual or automated retraction systems to maintain visualization without large incisions. According to Intuitive Surgical's February 2024 '2023 Annual Report on Form 10-K', worldwide da Vinci procedures grew approximately 22% compared to the previous year. This increase in advanced procedural volumes directly correlates with the need for compatible, often ergonomic or illuminated, instrumentation to ensure safety during complex internal maneuvers.
Simultaneously, the rising demand for reconstructive and cosmetic surgical procedures drives the procurement of specific retraction devices designed for aesthetic applications. These instruments must ensure optimal exposure while minimizing tissue damage to preserve aesthetic outcomes, necessitating a diverse range of geometries and sizes for body contouring, breast, and facial operations. As noted by the International Society of Aesthetic Plastic Surgery in its 'Global Survey 2023 Results' published in June 2024, plastic surgeons performed approximately 15.8 million surgical procedures worldwide, indicating a robust application area for these tools. This high volume of elective surgeries compels facilities to maintain extensive inventories of durable medical equipment. Consequently, general investment in surgical hardware remains high; according to Stryker, in 2024, the MedSurg and Neurotechnology segment reported net sales of $11.8 billion for the preceding fiscal year, reflecting substantial ongoing capital allocation toward essential surgical supplies and technologies.
Market Challenge
The stringent regulatory landscape regarding sterilization and the associated risk of surgical site infections with reusable devices presents a formidable barrier to the Global Surgical Retractors Market. Regulatory bodies increasingly mandate rigorous, time-consuming reprocessing protocols to mitigate contamination risks inherent in complex surgical instruments. These requirements compel healthcare facilities to invest heavily in specialized sterilization infrastructure and labor, significantly increasing the operational cost and turnaround time associated with reusable retractors. Consequently, the efficiency of surgical workflows is compromised, leading to reduced procedure throughput and a hesitancy among providers to expand their inventory of advanced reusable instrumentation.
This operational strain is compounded by the severe financial implications of sterilization failures. When reprocessing protocols are insufficient, the resulting infections deplete hospital budgets that could otherwise fund new equipment purchases. According to the Association for Professionals in Infection Control and Epidemiology, in 2024, surgical site infections resulted in an average hospital stay extension of nearly 10 days and an estimated $20,000 in additional hospitalization costs per patient. This profound economic burden forces institutions to prioritize infection control compliance and remediation over the acquisition of new surgical devices, thereby directly stifling broader market growth.
Market Trends
The market is being reshaped by the rising adoption of single-use disposable retractors, driven by the critical need to mitigate surgical site infections and eliminate complex reprocessing workflows. These devices are increasingly integrating advanced features such as cordless LED illumination to enhance visualization in deep cavities without the logistical burden of fiber optic cables. This shift is evident in the financial performance of key manufacturers investing in disposable technologies to meet heightened sterilization standards. According to CooperCompanies, May 2025, in the 'Second Quarter 2025 Earnings Call', the company reported that its OBP Surgical portfolio of single-use cordless surgical retractors generated 31% revenue growth, underscoring the rapid clinical acceptance of these sterile, ready-to-use instruments.
Concurrently, the growing demand for compact retractor systems in Ambulatory Surgery Centers (ASCs) is accelerating as high-acuity procedures migrate from inpatient hospital settings to outpatient environments. This transition necessitates specialized, space-efficient instrumentation designed to handle complex orthopedic and reconstruction cases within the streamlined infrastructure of an ASC. The expansion of outpatient arthroplasty, for instance, requires robust yet ergonomic retractors that function effectively in smaller operating rooms. According to Surgery Partners, November 2025, in the 'Third Quarter 2025 Earnings Call', the volume of total joint replacement surgeries performed in its ambulatory facilities grew 23% year-to-date, signaling a substantial increase in the utilization of procedure-specific retraction hardware tailored for outpatient surgical suites.
Report Scope
In this report, the Global Surgical Retractors Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Surgical Retractors Market.
Global Surgical Retractors Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: